Compliance Handbook for Pharmaceuticals, Medical Devices, and Biologics (eBook, PDF)
Redaktion: Medina, Carmen
63,95 €
63,95 €
inkl. MwSt.
Sofort per Download lieferbar
32 °P sammeln
63,95 €
Als Download kaufen
63,95 €
inkl. MwSt.
Sofort per Download lieferbar
32 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
63,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
32 °P sammeln
Compliance Handbook for Pharmaceuticals, Medical Devices, and Biologics (eBook, PDF)
Redaktion: Medina, Carmen
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This text lists the necessary steps for meeting compliance requirements during the drug development process. It presents comprehensive approaches for validating analytical methods for pharmaceutical applications.
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
- Größe: 3.22MB
Andere Kunden interessierten sich auch für
- Compliance Handbook for Pharmaceuticals, Medical Devices, and Biologics (eBook, ePUB)63,95 €
- David StokesTesting Computers Systems for FDA/MHRA Compliance (eBook, PDF)160,95 €
- Donald C. SingerLaboratory Auditing for Quality and Regulatory Compliance (eBook, PDF)63,95 €
- Charles SidebottomInternational Labeling Requirements for Medical Devices, Medical Equipment and Diagnostic Products (eBook, PDF)63,95 €
- Richard SchulzPatient Compliance with Medications (eBook, PDF)30,95 €
- FDA Regulatory Affairs (eBook, PDF)46,95 €
- Edward BauerPharmaceutical Packaging Handbook (eBook, PDF)189,95 €
-
-
-
This text lists the necessary steps for meeting compliance requirements during the drug development process. It presents comprehensive approaches for validating analytical methods for pharmaceutical applications.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis eBooks
- Seitenzahl: 704
- Erscheinungstermin: 9. Dezember 2003
- Englisch
- ISBN-13: 9780203026960
- Artikelnr.: 38173859
- Verlag: Taylor & Francis eBooks
- Seitenzahl: 704
- Erscheinungstermin: 9. Dezember 2003
- Englisch
- ISBN-13: 9780203026960
- Artikelnr.: 38173859
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Carmen Medina
Regulatory submissions
Patricia Fritz and Anisa Dhalla; compliance requirements during the drug development process
Martin D. Hynes; validation - a new perspective
James Agalloco; validating analytical methods for pharmaceutical applications - a comprehensive approach
Paul A. Winslow and Richard F. Meyer; the stability testing programme
Maria Geigel; computer validation - a compliance focus
Timothy Horgan and Timothy Carey; compliance issues associated with cleaning in the pharmaceutical industry
William E. Hall; the batch record - a blueprint for quality and compliance
John Fugate; change management - a far reaching
comprehensive and integrated system
Susan Freeman; the vendor qualification programme
Eizabeth M. Troll and Karen L. Hughes; handling laboratory and manufacturing deviations
Robert B. Kirsch; the internal audit programme - a quality assessment
Graham Bunn; pre-approval inspections - the critical compliance path to success
Martin D. Hynes; international compliance issues and trends
Alan G. Minsk; strategic planning for compliance and regulatory defensiveness
Ron Johnson; unique and unprecedented compliance challenges in the biologics area
Anne Hoppe and Curtiss Scribner; the impact of total quality performance on compliance
Carmen Medina
Judith Beach
Valerie Palumbo and Douglas B. Poucher.
Patricia Fritz and Anisa Dhalla; compliance requirements during the drug development process
Martin D. Hynes; validation - a new perspective
James Agalloco; validating analytical methods for pharmaceutical applications - a comprehensive approach
Paul A. Winslow and Richard F. Meyer; the stability testing programme
Maria Geigel; computer validation - a compliance focus
Timothy Horgan and Timothy Carey; compliance issues associated with cleaning in the pharmaceutical industry
William E. Hall; the batch record - a blueprint for quality and compliance
John Fugate; change management - a far reaching
comprehensive and integrated system
Susan Freeman; the vendor qualification programme
Eizabeth M. Troll and Karen L. Hughes; handling laboratory and manufacturing deviations
Robert B. Kirsch; the internal audit programme - a quality assessment
Graham Bunn; pre-approval inspections - the critical compliance path to success
Martin D. Hynes; international compliance issues and trends
Alan G. Minsk; strategic planning for compliance and regulatory defensiveness
Ron Johnson; unique and unprecedented compliance challenges in the biologics area
Anne Hoppe and Curtiss Scribner; the impact of total quality performance on compliance
Carmen Medina
Judith Beach
Valerie Palumbo and Douglas B. Poucher.
Regulatory submissions
Patricia Fritz and Anisa Dhalla; compliance requirements during the drug development process
Martin D. Hynes; validation - a new perspective
James Agalloco; validating analytical methods for pharmaceutical applications - a comprehensive approach
Paul A. Winslow and Richard F. Meyer; the stability testing programme
Maria Geigel; computer validation - a compliance focus
Timothy Horgan and Timothy Carey; compliance issues associated with cleaning in the pharmaceutical industry
William E. Hall; the batch record - a blueprint for quality and compliance
John Fugate; change management - a far reaching
comprehensive and integrated system
Susan Freeman; the vendor qualification programme
Eizabeth M. Troll and Karen L. Hughes; handling laboratory and manufacturing deviations
Robert B. Kirsch; the internal audit programme - a quality assessment
Graham Bunn; pre-approval inspections - the critical compliance path to success
Martin D. Hynes; international compliance issues and trends
Alan G. Minsk; strategic planning for compliance and regulatory defensiveness
Ron Johnson; unique and unprecedented compliance challenges in the biologics area
Anne Hoppe and Curtiss Scribner; the impact of total quality performance on compliance
Carmen Medina
Judith Beach
Valerie Palumbo and Douglas B. Poucher.
Patricia Fritz and Anisa Dhalla; compliance requirements during the drug development process
Martin D. Hynes; validation - a new perspective
James Agalloco; validating analytical methods for pharmaceutical applications - a comprehensive approach
Paul A. Winslow and Richard F. Meyer; the stability testing programme
Maria Geigel; computer validation - a compliance focus
Timothy Horgan and Timothy Carey; compliance issues associated with cleaning in the pharmaceutical industry
William E. Hall; the batch record - a blueprint for quality and compliance
John Fugate; change management - a far reaching
comprehensive and integrated system
Susan Freeman; the vendor qualification programme
Eizabeth M. Troll and Karen L. Hughes; handling laboratory and manufacturing deviations
Robert B. Kirsch; the internal audit programme - a quality assessment
Graham Bunn; pre-approval inspections - the critical compliance path to success
Martin D. Hynes; international compliance issues and trends
Alan G. Minsk; strategic planning for compliance and regulatory defensiveness
Ron Johnson; unique and unprecedented compliance challenges in the biologics area
Anne Hoppe and Curtiss Scribner; the impact of total quality performance on compliance
Carmen Medina
Judith Beach
Valerie Palumbo and Douglas B. Poucher.